» Articles » PMID: 7561427

Analysis of Local Recurrence Rates After Surgery Alone for Rectal Cancer

Overview
Date 1995 Jan 1
PMID 7561427
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Local recurrence (LR) continues to be a major problem following surgical treatment for rectal cancer, and proposed ways of reducing this remain controversial. The aim of this study was to review results from published surgical series in which adjuvant therapies were not used. A Medline search identified series published between January 1982 and December 1992 with follow-up on at least 50 patients with rectal cancer treated surgically for cure, without adjuvant therapy. Fifty one papers reported follow-up on 10,465 patients with a median LR rate of 18.5%. LR was 8.5%, 16.3% and 28.6% in Dukes' A, B and C patients respectively, 16.2% following anterior resection and 19.3% following abdominoperineal resection. Nine papers (1,176 patients) reported LR rates of 10% or less. LR was 7.1% in 1,033 patients having total mesorectal excision and 12.4% in 476 patients having extended pelvic lymphadenectomy. Routine cytocidal stump washout in 1,364 patients was associated with 12.2% LR, however a higher proportion (41%) also underwent total mesorectal excision. In 52% of cases, LR was reported to have occurred with no evidence of disseminated disease. Surgical technique is an important determinant of LR risk. LR rates of 10% or less can be achieved with surgery alone in expert hands.

Citing Articles

Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial.

Wang H, Zhang X, Leng B, Zhu K, Jiang S, Feng R Radiat Oncol. 2024; 19(1):118.

PMID: 39267085 PMC: 11395642. DOI: 10.1186/s13014-024-02506-6.


Investigation toward the economic feasibility of personalized medicine for healthcare service providers: the case of bladder cancer.

Savchenko E, Bunimovich-Mendrazitsky S Front Med (Lausanne). 2024; 11:1388685.

PMID: 38808135 PMC: 11130437. DOI: 10.3389/fmed.2024.1388685.


Upper limit of radiation treatment portals in rectal cancer: is it wise to keep using bony landmarks in the present era of 3D conformal treatment?.

Vankina S, Goyal S, Narayanan G Rep Pract Oncol Radiother. 2023; 28(4):565-569.

PMID: 37795231 PMC: 10547415. DOI: 10.5603/RPOR.a2023.0045.


Surveillance strategies following curative resection and non-operative approach of rectal cancer: How and how long? Review of current recommendations.

Lauretta A, Montori G, Guerrini G World J Gastrointest Surg. 2023; 15(2):177-192.

PMID: 36896297 PMC: 9988648. DOI: 10.4240/wjgs.v15.i2.177.


Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer.

Hanna C, OCathail S, Graham J, Adams R, Roxburgh C J Immunother Precis Oncol. 2022; 4(2):86-104.

PMID: 35663532 PMC: 9153256. DOI: 10.36401/JIPO-20-31.


References
1.
Balslev I, Pedersen M, Teglbjaerg P, Bone J, Jacobsen N, Overgaard J . Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer. 1986; 58(1):22-8. DOI: 10.1002/1097-0142(19860701)58:1<22::aid-cncr2820580106>3.0.co;2-q. View

2.
Malcolm A, Perencevich N, Olson R, Hanley J, Chaffey J, Wilson R . Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum. Surg Gynecol Obstet. 1981; 152(2):131-6. View

3.
Luukkonen P, Jarvinen H . Stapled vs hand-sutured ileoanal anastomosis in restorative proctocolectomy. A prospective, randomized study. Arch Surg. 1993; 128(4):437-40. DOI: 10.1001/archsurg.1993.01420160075012. View

4.
Macfarlane J, Ryall R, Heald R . Mesorectal excision for rectal cancer. Lancet. 1993; 341(8843):457-60. DOI: 10.1016/0140-6736(93)90207-w. View

5.
Belli L, Beati C, Frangi M, Aseni P, Rondinara G . Outcome of patients with rectal cancer treated by stapled anterior resection. Br J Surg. 1988; 75(5):422-4. DOI: 10.1002/bjs.1800750509. View